Literature DB >> 22491940

Less blood loss with tetrastarch.

Léonore Wetzel, Sibylle Kozek-Langenecker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22491940     DOI： 10.1007/s00134-012-2552-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  6 in total

1.  Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for volume expansion in cardiac surgery patients: the effects on perioperative bleeding and transfusion needs.

Authors:  Philippe J Van der Linden; Stefan G De Hert; Dirk Deraedt; Stefanie Cromheecke; Koen De Decker; Rudi De Paep; Inez Rodrigus; Anne Daper; Anne Trenchant
Journal:  Anesth Analg       Date:  2005-09       Impact factor: 5.108

2.  Limitations of in vitro experiments on hydroxyethyl starch solutions.

Authors:  Gisela Scharbert; Sibylle Kozek-Langenecker
Journal:  Anesth Analg       Date:  2007-09       Impact factor: 5.108

Review 3.  Influence of hydroxyethyl starch (HES) 130/0.4 on hemostasis as measured by viscoelastic device analysis: a systematic review.

Authors:  Christiane S Hartog; Dorit Reuter; Wolfgang Loesche; Michael Hofmann; Konrad Reinhart
Journal:  Intensive Care Med       Date:  2011-10-12       Impact factor: 17.440

4.  Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma).

Authors:  M F M James; W L Michell; I A Joubert; A J Nicol; P H Navsaria; R S Gillespie
Journal:  Br J Anaesth       Date:  2011-08-19       Impact factor: 9.166

5.  Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130/0.4.

Authors:  Christophe Hanart; Maher Khalife; Andrée De Villé; Florence Otte; Stefan De Hert; Philippe Van der Linden
Journal:  Crit Care Med       Date:  2009-02       Impact factor: 7.598

6.  Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarch.

Authors:  Sweeta D Gandhi; Richard B Weiskopf; Cornelius Jungheinrich; Robert Koorn; Diane Miller; Robert E Shangraw; Donald S Prough; Daniela Baus; Frank Bepperling; David C Warltier
Journal:  Anesthesiology       Date:  2007-06       Impact factor: 7.892
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.